This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Günter Klöppel
Introduction
Günter Klöppel is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of liver inflammation. His work has the potential to improve the diagnosis and treatment of liver-related diseases.
Latest Patents
Günter Klöppel holds a patent for "Biomarkers for inflammation of the liver." This invention relates to a method for the diagnostic investigation of biological samples from individuals for liver inflammation, specifically hepatic fibrosis and/or cirrhosis. The method involves analyzing samples for one or more proteins that serve as markers of liver inflammation. An elevated or decreased concentration of these proteins compared to a healthy state indicates the presence of liver inflammation. The proteins identified in this patent include ER6Q, vimentin, actin alpha 1 skeletal muscle protein, and several others.
Career Highlights
Throughout his career, Klöppel has worked with various companies, including Sitek. His expertise in the field of medical diagnostics has allowed him to contribute to advancements in understanding liver diseases. His innovative approach to identifying biomarkers has opened new avenues for research and clinical applications.
Collaborations
Günter Klöppel has collaborated with notable professionals in his field, including Wolff Schmiegel and Bence Sipos. These collaborations have further enhanced his research and development efforts in medical diagnostics.
Conclusion
Günter Klöppel's contributions to the field of liver inflammation diagnostics exemplify the impact of innovative thinking in medicine. His patent on biomarkers for liver inflammation represents a significant advancement in diagnostic methods, potentially improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile